Skip to main content
. 2004 Aug;78(16):8593–8600. doi: 10.1128/JVI.78.16.8593-8600.2004

FIG. 3.

FIG. 3.

Accumulation of cells with aberrant DNA content after cisplatin treatment of agnopositive and agnonegative cell lines. Agnopositive and agnonegative cells were left untreated or treated with cisplatin and subject to FACS analysis as described in Materials and Methods. (A) Agnonegative, untreated cells; (B) agnopositive, untreated cells; (C) agnonegative, cisplatin-treated cells; (D) agnopositive, cisplatin-treated cells.